Publications by authors named "Clare Sander"

Claim this Profile
E
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft--host disease in adults.
Saskia Bos, John Murray, Monia Marchetti, Guang-Shing Cheng, Anne Bergeron, Clare Sander

Eur Respir J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease.
Jonathan Cutajar, Effrossyni Gkrania-Klotsas, Clare Sander, Andres Floto, Anita Chandra

J Allergy Clin Immunol Glob· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Malcolm Begg, Augustin Amour, Emily Jarvis, Teresa Tang, Sara Santos Franco, Clare Sander

Pulm Pharmacol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18  influenza seasons.
Mark Reacher, Ben Warne, Neville Q Verlander, Ashley Popay, Lucy Reeve, Clare Sander

J Infect· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.
Anthony W Martinelli, Callum B Wright, Marta S Lopes, Rosemary L Swayne, Pramila Krishnamurthy, Clare R Sander

J Med Microbiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food for Thought: Dietary Intervention in a Rare Cause of Severe Ventilatory Failure.
Henry Yung, Keshav Sharma, William Flowers, Malcolm Marquette, Laura Starace, Clare Sander

Eur J Case Rep Intern Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.
Anthony W Martinelli, Parth Patil, Vanessa K Wong, David A Enoch, Clare R Sander

J Med Microbiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
Mark Reacher, Ben Warne, Lucy Reeve, Neville Q Verlander, Nicholas K Jones, Clare Sander

Euro Surveill· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
John R Hurst, Nisha Verma, David Lowe, Helen E Baxendale, Stephen Jolles, Clare R Sander

J Allergy Clin Immunol Pract· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late respiratory effects of cancer treatment.
Clare Harris, Clare R Sander

Curr Opin Support Palliat Care· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
Rachel Tanner, Kristina Kakalacheva, Ellen Miller, Ansar A Pathan, Rod Chalk, Clare R Sander

BMC Infect Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.
Angela M Minassian, Rosalind Rowland, Natalie E R Beveridge, Ian D Poulton, Iman Satti, Clare R Sander

BMJ Open· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Ansar A Pathan, Angela M Minassian, Clare R Sander, Rosalind Rowland, David W Porter

Vaccine· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
Kristin L Griffiths, Ansar A Pathan, Angela M Minassian, Clare R Sander, Natalie E R Beveridge

PLoS One· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
Simone C de Cassan, Ansar A Pathan, Clare R Sander, Angela Minassian, Rosalind Rowland

Clin Vaccine Immunol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
Kathryn T Whelan, Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton

PLoS One· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Clare R Sander, Ansar A Pathan, Natalie E R Beveridge, Ian Poulton, Angela Minassian

Am J Respir Crit Care Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
Elma Z Tchilian, Christiane Desel, Emily K Forbes, Silke Bandermann, Clare R Sander

Infect Immun· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
Natalie E R Beveridge, Helen A Fletcher, Jane Hughes, Ansar A Pathan, Thomas J Scriba, Clare R Sander

Tuberculosis (Edinb)· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
Emily K Forbes, Clare Sander, Edward O Ronan, Helen McShane, Adrian V S Hill

J Immunol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, Susanna J Dunachie, Kathryn T Whelan, Clare R Sander

Vaccine· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Clare R Sander

Am J Respir Crit Care Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.
Natalie E R Beveridge, David A Price, Joseph P Casazza, Ansar A Pathan, Clare R Sander

Eur J Immunol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder

PLoS One· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
Eung-Jun Im, Narcís Saubi, Goretti Virgili, Clare Sander, Denise Teoh

J Virol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis